Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [What Happened to New Gold Discoveries?]( [See why savvy investors are looking at U.S. gold projects right now.]( --------------------------------------------------------------- February 1, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [The Gold Dilemma Nobody Told You About]( flock to gold during times of uncertainty, instability, and geopolitical crisis. We saw this with the COVID-19 pandemic, the Russia-Ukraine war, and now the Israel-Hamas conflict. While analysts are increasingly bullish on the yellow metal, new gold discoveries are urgently needed to meet the projected future demand. [Read about this potential new American gold hotspot.]( --------------------------------------------------------------- [Tourmaline Bio, Inc.]( Ticker: [TRML]( Recent Price: $33.39 Average Analyst Price Target: $49.25 (47.50%) Market Cap: $679.07M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 100,000 $3,250,000 2 Days Ago Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [Tourmaline Bio, Inc. (TRML)]( in the Healthcare sector with a Buy rating and a price target of $48 (3 weeks ago). Here are 3rd party ratings for [TRML](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 40% (100 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Best way to buy gold today (not what you'd think)]( so many strange events happening across the economy (longest bear market for bonds since Civil War... unprecedented bank closures... and soaring prices) – it's no wonder the richest investors are loading up on gold. But what you might not realize is there's a much better way to profit from rising gold prices – without ever touching an ETF, mining stock, or even bullion. [Full details here.]( --------------------------------------------------------------- [Abbott Laboratories]( Ticker: [ABT]( Recent Price: $113.15 Average Analyst Price Target: $124.20 (9.77%) Market Cap: $196.44B Role Transaction Description No. of Shares Amount Date EVP Informative Buy Non Open Market Buy 19,000 $2,158,950 2 Days Ago Recent Analyst Action: Larry Biegelsen, analyst at Wells Fargo, reiterates coverage on [Abbott Laboratories (ABT)]( in the Healthcare sector with a Buy rating and a price target of $133 (5 days ago). Here are 3rd party ratings for [ABT](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 36% (161 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Akoustis Technologies, Inc.]( Ticker: [AKTS]( Recent Price: $0.57 Average Analyst Price Target: $1.50 (163.16%) Market Cap: $43.36M Role Transaction Description No. of Shares Amount Date CEO, Director Informative Buy Non Open Market Buy 1,149,120 $655,000 2 Days Ago Recent Analyst Action: Craig Ellis, analyst at B.Riley Financial, reiterates coverage on [Akoustis Technologies, Inc. (AKTS)]( in the Technology sector with a Hold rating and a price target of $1 (5 days ago). Here are 3rd party ratings for [AKTS](: - TipRanks.com: Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 8% (230 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [PaySign, Inc.]( Ticker: [PAYS]( Recent Price: $3.07 Average Analyst Price Target: $4.33 (41.15%) Market Cap: $161.96M Role Transaction Description No. of Shares Amount Date Other Informative Buy Non Open Market Buy 108,327 $331,257 2 Days Ago >10% Owner Informative Buy Non Open Market Buy 108,327 $331,257 2 Days Ago Recent Analyst Action: Peter Heckmann, analyst at D.A. Davidson, reiterates coverage on [PaySign, Inc. (PAYS)]( in the Technology sector with a Buy rating and a price target of $3 (2 months ago). Here are 3rd party ratings for [PAYS](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 42% (106 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Relmada Therapeutics, Inc.]( Ticker: [RLMD]( Recent Price: $3.93 Average Analyst Price Target: $17.50 (345.29%) Market Cap: $118.29M Role Transaction Description No. of Shares Amount Date CA and CO Informative Buy Non Open Market Buy 38,300 $150,754 2 Days Ago Recent Analyst Action: Uy Ear, analyst at Mizuho Securities, reiterates coverage on [Relmada Therapeutics, Inc. (RLMD)]( in the Healthcare sector with a Buy rating and a price target of $25 (3 weeks ago). Here are 3rd party ratings for [RLMD](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 40% (100 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message ["America's Icebox" to Help Solve Gold Supply Crisis?]( and Russia are the largest global gold producers. American reliance on imported minerals is at record levels, leaving us vulnerable to foreign suppliers cutting off shipments for geopolitical reasons. Experts are calling for more U.S. mining to build safe and reliable supply chains for precious and base metals. [See how investors could benefit from new Alaskan mining projects.]( --------------------------------------------------------------- [Roblox Corporation]( Ticker: [RBLX]( Recent Price: $38.81 Average Analyst Price Target: $45.80 (18.01%) Market Cap: $24.21B Role Transaction Description No. of Shares Amount Date CTO Informative Buy Non Open Market Buy 2,570 $99,851 2 Days Ago Recent Analyst Action: Nick McKay, analyst at Wedbush, reiterates coverage on [Roblox Corporation (RBLX)]( in the Communication Services sector with a Buy rating and a price target of $53 (23 hours ago). Here are 3rd party ratings for [RBLX](: - TipRanks.com: Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Bottom 39% (152 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Columbia Banking System, Inc.]( Ticker: [COLB]( Recent Price: $20.16 Average Analyst Price Target: $23.30 (15.58%) Market Cap: $4.21B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 2,141 $44,563 2 Days Ago SEVP Informative Buy Non Open Market Buy 5,000 $105,400 2 Days Ago President & CEO, Director Informative Buy Non Open Market Buy 9,500 $199,104 4 Days Ago Recent Analyst Action: Brandon King, analyst at Truist Financial, reiterates coverage on [Columbia Banking System, Inc. (COLB)]( in the Financial Services sector with a Hold rating and a price target of $22 (5 days ago). Here are 3rd party ratings for [COLB](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Strong Sell, Bottom 17% (208 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Melting Glaciers Could Uncover Once-Hidden Minerals]( glaciers are a serious worry for climate scientists. But for miners exploring the "frozen north's" Golden Triangle, melting glaciers could help locate and extract both base and precious metals that were previously untouchable. [See how a changing climate could open up new resource investing opportunities.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software